3793-3873 Screening compound: (2E)-N-{4-[(2,6-dimethylpyrimidin-4-yl)sulfamoyl]phenyl}-3-(4-ethoxy-3-methoxyphenyl)prop-2-enamide

3793-3873 Screening compound: (2E)-N-{4-[(2,6-dimethylpyrimidin-4-yl)sulfamoyl]phenyl}-3-(4-ethoxy-3-methoxyphenyl)prop-2-enamide
3793-3873 Screening compound: (2E)-N-{4-[(2,6-dimethylpyrimidin-4-yl)sulfamoyl]phenyl}-3-(4-ethoxy-3-methoxyphenyl)prop-2-enamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 3793-3873
(2E)-N-{4-[(2,6-dimethylpyrimidin-4-yl)sulfamoyl]phenyl}-3-(4-ethoxy-3-methoxyphenyl)prop-2-enamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3793-3873

Molecular Formula

C24H26N4O5S (C24 H26 N4 O5 S)

Compound Name

(2E)-N-{4-[(2,6-dimethylpyrimidin-4-yl)sulfamoyl]phenyl}-3-(4-ethoxy-3-methoxyphenyl)prop-2-enamide

IUPAC name

(2E)-N-{4-[(26-dimethylpyrimidin-4-yl)sulfamoyl]phenyl}-3-(4-ethoxy-3-methoxyphenyl)prop-2-enamide

SMILES

CCOc(ccc(/C=C/C(Nc(cc1)ccc1S(Nc1nc(C)nc(C)c1)(=O)=O)=O)c1)c1OC

InChI

InChI=1S/C24H26N4O5S/c1-5-33-21-12-6-18(15-22(21)32-4)7-13-24(29)27-19-8-10-20(11-9-19)34(30,31)28-23-14-16(2)25-17(3)26-23/h6-15H,5H2,1-4H3,(H,27,29)(H,25,26,28)

InChI Key

UPMDDWHKJDCFRC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02333672

Chemical and Physical Properties

Saltdata

HCl

Molecular Weight

482.56

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.035

Distribution Coefficient, logD

2.165

Water Solubility, LogSw

-3.53

Polar Surface Area

97.164

Acid Dissociation Constant (pKa)

6.59

Base Dissociation Constant (pKb)

5.80

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.80

3793-3873 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

KRAS-Targeted Library (16000 compounds)

Covalent Inhibitors Library (7986 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Structure:
  • Cyclic compounds
  • 3D
  • Fragments

References: we are preparing a list of scientific research reports with 3793-3873 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3793-3873?
Check Price and Availability of 3793-3873, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3793-3873 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3793-3873
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3793-3873
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3793-3873 available by request